The occurrence of pseudoexfoliation (PSX) foliowing penetrating keratoplasty for keratoconus is reported in three eyes of two patients. The patients' ages at keratoplasty were 37, 40, and 31 years, and PSX was first observed 5, 4, and 6 years foliowing keratoplasty. The donor age was 76, 81, and 81 years. Possible explanations for the occurrence of PSX after keratoplasty include mere coincidence, some sort of non-specific reaction to surgery or to postoperative medication, an immunogenic reaction to transplanted foreign corneal tissue, and the hypothetical speculation that PSX might be a transmissible disease.
Pseudoexfoliation (PSX) syndrome is clinically characterised by typical morphological changes of the anterior ocular segment. Despite numerous investigations its exact aetiology is still unknown.
We report three eyes of two relatively young patients with keratoconus in which PSX developed 4 to 6 years after corneal transplantation from donors over 75 years old.
Case reports CASE 1
A 37-year-old white female was referred for treatment of bilateral keratoconus in 1981 . Her family history aind general history were uncontributory. Ocular examination of both eyes did not reveal any abnormality, except for bilateral keratoconus, especially no signs of PSX. Both eyes underwent 7T8/7'5 mm penetrating keratoplasty (right eye on 29 October 1981, left eye on 4 October 1984). The donors were a 76-year-old male and an 81-year-old male, respectively who had both died of myocardial infarction. The donor eyes were not specifically screened for PSX and were not available for histological examination. Postoperative medications were local corticosteroids (prednisolone acetate 1%) for 1 year and scopolamine eyedrops for 6 weeks. The postoperative courses were unremarkable in both eyes, and corrected visual acuity was 6/6 right and 6/7 left after suture removal. Both eyes underwent regular slit-lamp examination every 3 to 6 months by one ofus (GOHN). In November 1986, 5 years after keratoplasty, the right eye showed signs of PSX for the first time (Fig 1) Our observation of the development of PSX after penetrating keratoplasty could be interpreted in several ways.
(1) The occurrence could be purely coincidental. However our patients' ages at the development of PSX (42, 44, and 37 years) was exceptionally young. PSX is usually seen in older patients and only occasionally occurs in patients under age 50 although the youngest patient with PSX reported in the literature was only 31 years.'0 In our patients there was also a striking constancy of the interval between keratoplasty and development of PSX which was 4 to 6 years. (2) The development of PSX could represent a non-specific reaction to intraocular surgery or to local medication thus leading to the manifestation of PSX several years after keratoplasty. ( 3) The development of PSX could be the result of an immunogenic interaction between the host and the transplanted donor corneal tissue. The rather constant interval between keratoplasty and development of PSX could fit in with this hypothesis. (4) PSX could be a somewhat transmissible disease that in our patients was transmitted from the donors to the recipients by means of the corneal buttons. Unfortunately we do not know whether the donor eyes showed signs of PSX but as the donors were between 76 and 81 years of age and the prevalence of PSX is high in this age group it is possible that the donor eyes were affected by PSX. This speculation would again go well with the typical interval between keratoplasty and development of PSX in our patients and would also give some sort of explanation of the frequent occurrence of PSX in married couples seen by other investigators. 1 ' 14 Although the exact meaning of our observations is uncertain at present similar findings by other investigators may give important clues of the aetiology and pathogenesis of PSX in the future. 
